Analyst Ratings for Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (CBD)

Updated: 2017-07-27

Companhia Brasileira de Distribuicao Grupo Pao de Acucar ADR (NYSE:CBD) was awarded an average rating of Overweight from investment analysts following the stock. A consensus rating of Overweight was previously issued for CBD last month.

A buy rating was issued by 8 analysts, 0 gave an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Investment analysts gave a few price targets for CBD. The highest price target was 27.88, which equates to a potential upside of 22.77 percent. The most pessimistic analyst gave a price target of 21.17, implying potential capital losses of -6.78 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates upwards for this quarter, by about 250 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is 0 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.94 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.14 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 1 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 1 analysts increased their estimates for the FY earnings, while 2 analysts decreased their estimates.

In the last 52-weeks, CBD has achieved a high of 24.75 and a low of 14.08. Currently the stock is 61.29 percent higher than its low, and 8.24 percent lower than its 52-week high. CBD has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The CBD value stock report compares CBD to some of its peers using value stock charts. The market cap of CBD is $5.18 billion. CBD will post this quarters earnings in days, on 0000-00-00.